These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4253067)

  • 1. The influence of glucagon on myocardial mechanics of papillary muscles obtained from patients with chronic congestive heart failure.
    Strauer BE
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(1):90-3. PubMed ID: 4253067
    [No Abstract]   [Full Text] [Related]  

  • 2. Diminished responsiveness of the failing human myocardium to glucagon.
    Parmley WW; Chuck L; Matloff J
    Cardiology; 1970; 55(4):211-7. PubMed ID: 5520044
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol.
    Glick G; Parmley WW; Wechsler AS; Sonnenblick EH
    Circ Res; 1968 Jun; 22(6):789-99. PubMed ID: 5659816
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of chronic heart failure on the capacity of glucagon to enhance contractility and adenyl cyclase activity of human papillary muscles.
    Goldstein RE; Skelton CL; Levey GS; Glancy DL; Beiser GD; Epstein SE
    Circulation; 1971 Oct; 44(4):638-48. PubMed ID: 5094143
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac actions of glucagon.
    Lucchesi BR
    Circ Res; 1968 Jun; 22(6):777-87. PubMed ID: 4385510
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase.
    Gold HK; Prindle KH; Levey GS; Epstein SE
    J Clin Invest; 1970 May; 49(5):999-1006. PubMed ID: 5441551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of glucagon with theophylline, PGE1, isoproeerenol, ouabain, and CaC1 on the dog isolated papillary muscle.
    Antonaccio MJ; Lucchesi BR
    Life Sci I; 1970 Oct; 9(19):1081-9. PubMed ID: 5482442
    [No Abstract]   [Full Text] [Related]  

  • 8. Inotropic effects of isoflurane on mechanics of contraction in isolated cat papillary muscles from normal and failing hearts.
    Kemmotsu O; Hashimoto Y; Shimosato S
    Anesthesiology; 1973 Nov; 39(5):470-7. PubMed ID: 4746052
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of glucagon on calcium exchangeability, coronary blood flow, myocardial function and high energy phosphate stores.
    Nayler WG; McInnes I; Chipperfield D; Carson V; Daile P
    J Pharmacol Exp Ther; 1970 Feb; 171(2):265-75. PubMed ID: 5459062
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiologic effects of glucagon on human cardiac muscle.
    Prasad K
    Clin Pharmacol Ther; 1975 Jul; 18(1):22-30. PubMed ID: 1149358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiac effect of glucagon. Electrophysiologic measurements in the papillary muscle of the heart].
    Lüderitz B; Bolte HD
    Z Kreislaufforsch; 1971 Feb; 60(2):130-5. PubMed ID: 5123093
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of glucagon on the transmembrane potential, contraction, and ATPase activity of the failing human heart.
    Prasad K
    Cardiovasc Res; 1972 Nov; 6(6):684-95. PubMed ID: 4266319
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of changes in time interval of stimulation on mechanics of isolated heart muscle and its response to ethrane.
    Iwatsuki N; Shimosato S; Etsten BE
    Anesthesiology; 1970 Jan; 32(1):11-6. PubMed ID: 5409583
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary effect of glucagon on positive chronotropism.
    Kimura T; Kokubun M; Hashimoto K
    Jpn J Pharmacol; 1974 Apr; 24(2):279-83. PubMed ID: 4546888
    [No Abstract]   [Full Text] [Related]  

  • 15. Paradoxical effects of epinephrine on excitation-contraction coupling in cardiac muscle.
    Kavaler F; Morad M
    Circ Res; 1966 May; 18(5):492-501. PubMed ID: 5949269
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of the inotropic effects of glucagon by theophylline.
    Marcus ML; Skelton CL; Prindle KH; Epstein SE
    J Pharmacol Exp Ther; 1971 Nov; 179(2):331-7. PubMed ID: 4332326
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of the inotropic action of glucagon by small concentration of angiotensin.
    Inoue K; Smulyan H; Mucha E; Eich RH
    Jpn Heart J; 1973 May; 14(3):239-48. PubMed ID: 4353886
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of strontium ions on heart muscle. I. Influences on contractility.
    Weyne J
    Arch Int Physiol Biochim; 1966 Jun; 74(3):449-60. PubMed ID: 4162226
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative description of inotropic agents in vitro.
    Spilker BA
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):325-41. PubMed ID: 4694369
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of tyramine on the atrium and the papillary muscle of the immunosympathectomized rat.
    Varma DR; Ayitey-Smith E
    J Pharm Pharmacol; 1967 Aug; 19(8):557-9. PubMed ID: 4382448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.